SE8604349D0 - DIKLORANILINDERIVAT - Google Patents

DIKLORANILINDERIVAT

Info

Publication number
SE8604349D0
SE8604349D0 SE8604349A SE8604349A SE8604349D0 SE 8604349 D0 SE8604349 D0 SE 8604349D0 SE 8604349 A SE8604349 A SE 8604349A SE 8604349 A SE8604349 A SE 8604349A SE 8604349 D0 SE8604349 D0 SE 8604349D0
Authority
SE
Sweden
Prior art keywords
group
hydrogen atom
alkoxy
hydroxy
alkyl group
Prior art date
Application number
SE8604349A
Other languages
Swedish (sv)
Other versions
SE8604349L (en
SE467541B (en
Inventor
I F Skidmore
L H C Lunts
H Finch
A Naylor
I B Campbell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8604349D0 publication Critical patent/SE8604349D0/en
Publication of SE8604349L publication Critical patent/SE8604349L/en
Publication of SE467541B publication Critical patent/SE467541B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45—Monoamines
    • C07C211/46—Aniline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compounds of the formula (I> <IMAGE> wherein X represents a bond, C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene and Y represents a bond, C1-4 alkylene, C2-4 alkenylene or C2-4 alkynylene, the sum total of carbon atoms in X and Y being not more than 8; Ar represents a phenyl group substituted by one or more substituents selected from nitro, -(CH2)qR [where R is C1-3 alkoxy, -NR<3>R<4> (where R<3> and R<4> each represent a hydrogen atom, or a C1-4 alkyl group, or-NR<3>R<4> forms a saturated heterocyclic amino group which has 5-7 ring members), -NR<5>COR<6> (where R<5> represents a hydrogen atom or a C1-4alkyl group, and R<6> represents a hydrogen atom or a C1-4alkyl, C1-4alkoxy or-NR<3>R<4> group), and q is 1 to 3], -(CH2)rR<7> [where R<7> represents -NR<5>SO2R<8> (where R<8> represents a C1-4 alkyl, phenyl or -NR<3>R<4> group),- NR<5>COCH2N(R<5>)2 (where each of the groups R<5> represents a hydrogen atom or a C1-4 alkyl group), -COR<9 > (where R<9> represents hydroxy, C1-4 alkoxy or a NR<3>R<4>), -SR<10> (where R<10> is a hydrogen atom, or a C1-4 alkyl group optionally substituted by hydroxy, C1-4 alkoxy or NR<3>R<4>), -SOR<10>, -SO2R10, -CN, or -NR11R<12> (where R<11> and R<12> represent a hydrogen atom or a C1-4 alkyl group, at least one of which is C2-4 alkyl substituted by a hydroxy, C1-4 alkoxy or NR<3>R<4> group), and r is 0 to 3], -O(CH2)qCOR<9>, or -O(CH2)tR<13> [where R<13> represents hydroxy, NR<3>R<4>, NR<11>R<12> or a C1-4alkoxy group optionally substituted by hydroxy, C1-4 alkoxy or NR<3>R<4>,and t is 2 or 3]. R<1> and R<2> each represents a hydrogen atom or a C1-3 alkyl group, the sum total of carbon atoms in R<1> and R<2> being not more than 4; and physiologically acceptable salts and solvates (e.g. hydrates) thereof, have a stimulant action at a beta 2-adreno-receptors and may be used in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis.
SE8604349A 1985-10-15 1986-10-14 DICHLORANILIN DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS SE467541B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525321A GB8525321D0 (en) 1985-10-15 1985-10-15 Chemical compounds

Publications (3)

Publication Number Publication Date
SE8604349D0 true SE8604349D0 (en) 1986-10-14
SE8604349L SE8604349L (en) 1987-04-16
SE467541B SE467541B (en) 1992-08-03

Family

ID=10586651

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604349A SE467541B (en) 1985-10-15 1986-10-14 DICHLORANILIN DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS

Country Status (21)

Country Link
JP (1) JPS62149651A (en)
KR (1) KR870003970A (en)
AT (1) AT395972B (en)
AU (1) AU591188B2 (en)
BE (1) BE905601A (en)
CA (1) CA1296335C (en)
CH (1) CH669787A5 (en)
DE (1) DE3634974A1 (en)
DK (1) DK491786A (en)
ES (1) ES2002036A6 (en)
FI (1) FI89164C (en)
FR (1) FR2591590B1 (en)
GB (2) GB8525321D0 (en)
IE (1) IE59466B1 (en)
IL (2) IL78432A (en)
IT (1) IT1205360B (en)
NL (1) NL8602575A (en)
NO (1) NO164895C (en)
PT (1) PT83531B (en)
SE (1) SE467541B (en)
ZA (1) ZA867772B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173685A (en) * 1984-04-17 1985-10-18 Glaxo Group Ltd Safety and pouring stopper
US5149698A (en) * 1987-08-11 1992-09-22 Glaxo Group Limited Chloroaniline derivatives
GB8718939D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
GB8718938D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
JPH0228141A (en) * 1987-11-13 1990-01-30 Glaxo Group Ltd Phenethanolamine derivative
ZA889405B (en) * 1987-12-18 1989-12-27 Glaxo Group Ltd Ethanolamine derivatives
DE3884363T2 (en) * 1987-12-18 1994-01-20 Glaxo Group Ltd Ethanolamine derivatives.
GB8808892D0 (en) * 1988-04-15 1988-05-18 British Bio Technology Gene synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (en) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Process for the preparation of new amino-dihalogen-phenyl-ethylamines
DE2351281C3 (en) * 1973-10-12 1981-07-30 Dr. Karl Thomae Gmbh, 7950 Biberach Aminophenylethanolamine derivatives, their production and use
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
DK173685A (en) * 1984-04-17 1985-10-18 Glaxo Group Ltd Safety and pouring stopper
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds

Also Published As

Publication number Publication date
GB2182658B (en) 1990-01-31
FI864137A (en) 1987-04-16
IE862707L (en) 1987-04-15
PT83531A (en) 1986-11-01
AU6395986A (en) 1987-04-16
IL80294A (en) 1990-11-29
SE8604349L (en) 1987-04-16
AT395972B (en) 1993-04-26
AU591188B2 (en) 1989-11-30
JPS62149651A (en) 1987-07-03
IL78432A (en) 1990-09-17
SE467541B (en) 1992-08-03
ES2002036A6 (en) 1988-07-01
GB2182658A (en) 1987-05-20
CH669787A5 (en) 1989-04-14
NO864101D0 (en) 1986-10-14
IT1205360B (en) 1989-03-15
IT8648547A0 (en) 1986-10-14
FR2591590B1 (en) 1990-05-11
BE905601A (en) 1987-04-15
DK491786A (en) 1987-04-16
FR2591590A1 (en) 1987-06-19
KR870003970A (en) 1987-05-06
DE3634974A1 (en) 1987-05-27
PT83531B (en) 1989-05-31
NO164895B (en) 1990-08-20
NO864101L (en) 1987-04-21
IE59466B1 (en) 1994-02-23
FI864137A0 (en) 1986-10-14
FI89164B (en) 1993-05-14
ZA867772B (en) 1988-07-27
GB8525321D0 (en) 1985-11-20
DK491786D0 (en) 1986-10-14
ATA273486A (en) 1992-09-15
NO164895C (en) 1990-11-28
GB8624630D0 (en) 1986-11-19
NL8602575A (en) 1987-05-04
CA1296335C (en) 1992-02-25
FI89164C (en) 1993-08-25

Similar Documents

Publication Publication Date Title
FI820281L (en) FREQUENCY COMPOSITION FOR 2-PENEMICAL COMPOSITION WITH FRAMEWORK FOR 2-PENEMICAL COMPOSITION OF THE EUROPEAN PHARMACEUTICAL FORM
SE8700535L (en) DIKLORANILINDERIVAT
PT82386B (en) PROCESS FOR THE PREPARATION OF DICHLOROANILINE DERIVATIVES
ATE39350T1 (en) AMINOPHENOL DERIVATIVES.
SE8503466L (en) aminophenol compounds
SE8604349D0 (en) DIKLORANILINDERIVAT
DE69311118D1 (en) PHOSPHONO-ARYLETHANOLAMINE COMPOUNDS WITH ANTI-HYPERGLYCEMIC AND / OR ANTIOBESIC EFFECT
ES2069841T3 (en) NEW DERIVATIVES OF IMIDAZO- (1,2-C) -QUINAZOLINA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES508343A0 (en) &#34;PROCEDURE FOR THE PREPARATION OF NEW PIRIMIDO (5,4-D) PIRIMIDINAS TRISUSTITUIDAS&#34;.
ES8404312A1 (en) Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application.
DE3668456D1 (en) 8-THIOTETRAHYDROQUINOL DERIVATIVES AND THEIR SALTS.
ES8105319A1 (en) Pyrazolo[1,5-c]quinazoline derivatives and analgesic compositions containing them
DE69204859D1 (en) Substituted pyridine sulfonamides or their salts, processes for their preparation and herbicides containing them.
DE69011748D1 (en) Biphenyl derivatives, processes for their preparation and their intermediates.
ES2040223T3 (en) DERIVATIVES OF THE TIADIAZOLILACETAMIDA, PROCEDURE FOR ITS MANUFACTURE AND ITS USE.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8604349-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8604349-4

Format of ref document f/p: F